Ventricular Arrythmias
7
0
0
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
14.3%
1 terminated out of 7 trials
75.0%
-11.5% vs benchmark
29%
2 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Efficacy of the ATP Switch Automatic Programming in Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronization Therapy Defibrillator (CRT-D) Implanted Patients
Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds
Sleep Apnea-hypopnea Syndrome (SAHS) and Ventricular Arrhythmias
Home-Monitoring in Implantable Cardioverter Defibrillator (ICD) Patients
Effect of Ranolazine on Arrhythmias and Microvolt T- Wave Alternans (MVTWA) Patients With LV Dysfunction
Effect of Remote Ischemic Preconditioning on Cardiac Function After Cardiac Surgery
The V-Tachogram:Decreasing Ventricular Arrythmias When Injecting Contrast in the Left Ventricle